Definition/General

Introduction:
-Colorectal tubulovillous adenoma is a mixed adenomatous polyp combining features of both tubular and villous adenomas
-Contains 25-75% villous architecture
-Represents 15-20% of all colorectal adenomas
-Higher malignant potential than pure tubular adenomas.
Origin:
-Arises from colonic epithelium through adenoma-carcinoma sequence
-Develops from aberrant crypt foci
-Results from accumulation of genetic mutations
-Shows progressive architectural complexity and dysplasia
-Part of adenomatous polyposis spectrum.
Classification:
-Classified by architectural pattern: >75% tubular (tubular adenoma)
-25-75% villous (tubulovillous adenoma)
->75% villous (villous adenoma)
-Dysplasia grading: Low-grade dysplasia (mild/moderate)
-High-grade dysplasia (severe/carcinoma in situ).
Epidemiology:
-Peak incidence in 6th-7th decades
-Male predominance (2:1 ratio)
-More common in left-sided colon
-Associated with Western lifestyle
-Indian population shows increasing incidence with dietary changes.

Clinical Features

Presentation:
-Often asymptomatic (detected on screening)
-Rectal bleeding (most common symptom)
-Change in bowel habits
-Mucus discharge
-Tenesmus (rectal lesions)
-Large polyps may cause obstruction.
Symptoms:
-Bright red bleeding per rectum (50-60% cases)
-Mucoid diarrhea (large villous component)
-Abdominal pain (cramping)
-Iron deficiency anemia (chronic bleeding)
-Hypokalemia (massive villous adenomas).
Risk Factors:
-Age >50 years
-Western diet (high fat, low fiber)
-Obesity
-Smoking
-Alcohol consumption
-Family history of colorectal cancer
-Inflammatory bowel disease.
Screening:
-Colonoscopy (gold standard)
-Fecal occult blood testing
-CT colonography
-Flexible sigmoidoscopy
-Fecal immunochemical test (FIT)
-Multitarget stool DNA test.

Master Tubulovillous Adenoma Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Pedunculated or sessile polyp
-Velvety surface (villous areas)
-Lobulated contour
-Red-pink to tan coloration
-Friable consistency
-May show surface erosions.
Characteristics:
-Cauliflower-like appearance
-Soft, friable consistency
-Cut surface shows complex architecture
-Papillary projections visible
-Areas of induration (high-grade dysplasia)
-Surface ulceration possible.
Size Location:
-Size typically 1-5 cm (larger than tubular)
-Sigmoid colon (most common site)
-Rectum (second most common)
-Left-sided predominance
-Usually solitary
-Multiple adenomas in polyposis syndromes.
Multifocality:
-Usually solitary (sporadic cases)
-Multiple adenomas (20-30% cases)
-Synchronous carcinomas (5% cases)
-Metachronous lesions (surveillance needed)
-FAP association (numerous polyps).

Microscopic Description

Histological Features:
-Mixed tubular and villous architecture
-Finger-like villous projections
-Dysplastic epithelium lining surface and crypts
-Lamina propria core in villi
-Inflammatory infiltrate in stroma
-Surface maturation may be lost.
Cellular Characteristics:
-Columnar epithelial cells with loss of polarity
-Nuclear stratification (pseudostratification)
-Hyperchromatic nuclei
-Increased nuclear-cytoplasmic ratio
-Mitotic figures above crypt base
-Mucin depletion in dysplastic areas.
Architectural Patterns:
-Tubular component: branched crypts with rounded profiles
-Villous component: finger-like projections with fibrovascular cores
-Complex crypts with budding
-Back-to-back glands (high-grade dysplasia)
-Cribriform pattern may develop.
Grading Criteria:
-Low-grade dysplasia: mild architectural distortion, nuclear changes confined to lower 2/3 of crypt
-High-grade dysplasia: severe architectural complexity, nuclear changes extending to surface
-Loss of surface maturation
-Carcinoma in situ (intramucosal carcinoma).

Immunohistochemistry

Positive Markers:
-CDX2 (intestinal differentiation)
-CK20 (colonic epithelium)
-CEA (apical staining, normal)
-p53 (may be positive in high-grade dysplasia)
-Ki-67 (proliferation marker).
Negative Markers:
-CK7 (usually negative)
-TTF-1 (negative)
-p53 (wild-type staining in low-grade)
-Chromogranin A (unless neuroendocrine differentiation)
-Vimentin (negative in epithelium).
Diagnostic Utility:
-CDX2 positivity confirms intestinal origin
-p53 staining pattern helps assess dysplasia grade
-Ki-67 index reflects proliferative activity
-β-catenin may show nuclear accumulation
-CK20 pattern maintains polarity.
Molecular Subtypes:
-Microsatellite stable (most common)
-Microsatellite unstable (Lynch syndrome)
-CpG island methylator phenotype (CIMP)
-Traditional adenoma pathway (APC mutations)
-Serrated pathway (rare in tubulovillous).

Molecular/Genetic

Genetic Mutations:
-APC gene mutations (60-80% cases)
-KRAS mutations (40-50% cases)
-TP53 mutations (high-grade dysplasia)
-PIK3CA mutations (20-30% cases)
-SMAD4 mutations (advanced lesions).
Molecular Markers:
-Wnt pathway activation (β-catenin nuclear localization)
-p53 accumulation (mutation-dependent)
-EGFR overexpression
-Loss of 18q (SMAD4 region)
-Chromosomal instability (CIN pathway).
Prognostic Significance:
-Size >1 cm increases malignancy risk
-Villous component >25% higher risk
-High-grade dysplasia significant risk factor
-TP53 mutations indicate progression risk
-Complete excision curative for benign adenomas.
Therapeutic Targets:
-Endoscopic resection (treatment of choice)
-Surgical resection (large lesions, malignancy)
-COX-2 inhibitors (prevention, controversial)
-Surveillance colonoscopy (monitoring)
-Polypectomy with clear margins.

Differential Diagnosis

Similar Entities:
-Tubular adenoma (<25% villous component)
-Villous adenoma (>75% villous component)
-Serrated adenoma (serrated architecture)
-Adenocarcinoma (invasive component)
-Inflammatory polyp (reactive).
Distinguishing Features:
-Tubulovillous adenoma: 25-75% villous architecture
-Tubulovillous adenoma: Mixed pattern
-Tubular adenoma: <25% villous
-Villous adenoma: >75% villous
-Serrated adenoma: Serrated crypts
-Adenocarcinoma: Stromal invasion.
Diagnostic Challenges:
-Distinguishing high-grade dysplasia from adenocarcinoma (basement membrane integrity)
-Assessing completeness of excision
-Quantifying villous component percentage
-Identifying focus of invasion
-Adequate sampling essential.
Rare Variants:
-Adenoma with mixed differentiation
-Adenoma with neuroendocrine cells
-Adenoma with squamous differentiation
-Adenoma in inflammatory bowel disease
-Flat adenoma (lateral spreading tumor).

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

Tubulovillous Adenoma

Location

Location: [anatomical site in colon/rectum]

Architectural Features

Shows mixed tubular and villous architecture with [X]% villous component. Finger-like villous projections with fibrovascular cores present.

Dysplasia Grade

Dysplasia: [Low-grade/High-grade] dysplasia

Size and Extent

Size: [X] cm, [pedunculated/sessile] polyp

Margin Assessment

Excision margins: [Complete/Incomplete] - [distance to nearest margin] mm

Special Features

Surface ulceration: [Present/Absent]. Adenomatous tissue extends to: [specify level]

Final Diagnosis

Colorectal Tubulovillous Adenoma with [low-grade/high-grade] dysplasia